The Manufacturing, Engineering and Regulation of Pluripotent Stem Cell-Derived Therapies

Online

As more stem cell discoveries are translated, the development of products based on these discoveries will depend on solving manufacturing challenges, including the scale-up or scale-out of products to achieve commercial quantities and qualities. This four-part meeting series is aimed at addressing these manufacturing and regulatory challenges to bring promising new cell therapies to the clinic.


This event will take place on 10, 17, 24 May and 1 June 2021. Companies interested in sponsoring an ISSCR Digital program, can reach out to ISSCR Industry Relations at exhibits@isscr.org.

LEARN MORE SIGN UP FOR EMAIL